Edition:
India

CVS Health Corp (CVS.N)

CVS.N on New York Stock Exchange

71.90USD
16 Feb 2018
Change (% chg)

$1.41 (+2.00%)
Prev Close
$70.49
Open
$70.37
Day's High
$72.20
Day's Low
$70.32
Volume
1,855,925
Avg. Vol
2,067,103
52-wk High
$84.00
52-wk Low
$66.46

Chart for

About

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc. (Omnicare) and Omnicare's long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other... (more)

Overall

Beta: 0.90
Market Cap(Mil.): $78,194.16
Shares Outstanding(Mil.): 1,016.57
Dividend: 0.50
Yield (%): 2.60

Financials

  Industry Sector
P/E (TTM): -- 20.98 16.64
EPS (TTM): -- -- --
ROI: -- 11.72 10.66
ROE: -- 13.91 14.30

UPDATE 4-CVS pledges to reinvest much of its tax savings, shares fall

Feb 8 CVS Health Corp warned on Thursday that its operating profit could fall this year as it plans to spend most of its $1.2 billion savings from the new U.S. tax law on reducing debt and paying employees more rather than boosting short-term profit.

08 Feb 2018

CVS to raise minimum wage of workers; profit beats

NEW YORK Drugstore chain and pharmacy benefits manager CVS Health Corp said on Thursday it would use part of a $1.2 billion savings from the new U.S. corporate tax law to increase hourly pay for its workers and reported fourth-quarter revenue and earnings that beat expectations.

08 Feb 2018

CVS says Aetna acquisition still expected in 2018

NEW YORK CVS Health Corp on Thursday said that a request for more information from U.S. antitrust regulators reviewing its proposed $69 billion acquisition of health insurer Aetna Inc does not impact its expectation that the deal will close in the second half of 2018.

08 Feb 2018

CVS says Aetna acquisition still expected in 2018

NEW YORK, Feb 8 CVS Health Corp on Thursday said that a request for more information from U.S. antitrust regulators reviewing its proposed $69 billion acquisition of health insurer Aetna Inc does not impact its expectation that the deal will close in the second half of 2018.

08 Feb 2018

BRIEF-CVS Health Sees Q1 2018 Net Revenue Growth For Retail/LTC Between 4 Pct To 5.5 Pct

* CVS HEALTH SEES PHARMACY SERVICES NET REVENUE CHANGE OF 1.5 PERCENT TO 3.5 PERCENT FOR FULL-YEAR 2018 - PRESENTATION SLIDES‍​

08 Feb 2018

BRIEF-CVS Health To Invest In Wage Increases And Benefits Following Tax Cuts and Jobs Act

* CVS HEALTH INVESTING IN LONG-TERM AND SUSTAINABLE WAGE INCREASES AND BENEFITS ENHANCEMENTS FOLLOWING THE PASSAGE OF THE TAX CUTS AND JOBS ACT

08 Feb 2018

CVS fourth quarter profit jumps in wake of U.S. tax law

NEW YORK, Feb 8 CVS Health Corp, which said in December it would buy health insurer Aetna Inc in a $69 billion deal, posted a jump in profit on Thursday, helped by savings from the biggest overhaul of the U.S. tax code in 30 years.

08 Feb 2018

UPDATE 1-Hudson's Bay names CVS Health veteran as new CEO

Feb 5 Saks Fifth Avenue-owner Hudson's Bay Co on Monday named veteran CVS Health Corp executive Helena Foulkes as its chief executive officer, replacing Richard Baker, who has been heading the company on an interim basis.

05 Feb 2018

Hudson's Bay names CVS Health executive as new CEO

Feb 5 Saks Fifth Avenue-owner Hudson's Bay Co on Monday appointed Helena Foulkes as its chief executive officer, replacing Richard Baker, effective Feb. 19.

05 Feb 2018

UPDATE 3-Lazard Q4 beats estimates, tax changes complicate conversion plans

NEW YORK Feb 1 Asset manager and advisory firm Lazard Ltd said on Thursday that it is reviewing whether to convert into a "C Corporation" from its current status as a public partnership after changes to the U.S. tax code mean such a conversion could raise its effective tax rate by about 10 percentage points.

02 Feb 2018

Competitors

Earnings vs. Estimates